Prostaglandins E2 and F2α reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 PART I, 1998, Pages 1374-1378

  Kharitonov, Sergei A ^a   Sapienza, Maria A ^a   Barnes, Peter J ^a   Chung, K Fan ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; DIAGNOSTIC AGENT; ENZYME INHIBITOR; METHACHOLINE CHLORIDE;

ADULT; AIRWAY; ARTICLE; ASTHMA; BRONCHOSPASM; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; BRONCHUS; DRUG ANTAGONISM; DRUG EFFECT; INHALATION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHI; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CHEMILUMINESCENT MEASUREMENTS; DINOPROST; DINOPROSTONE; ENZYME INHIBITORS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0031788770     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.5.9707076     Document Type: Article

References (34)

1. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
2. Barnes, P. J., and F. Y. Liew. 1995. Nitric oxide and asthmatic inflammation. Immunol. Today 16:128-130.
3. Barnes, P. J., and M. B. Belvisi. 1993. Nitric oxide and lung disease. Thorax 48:1034-1043.
4. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-551.
5. Gustafsson, L. E., A. M. Leone, M. G. Persson, N. P. Wiklund, and S. Moncada. 1991. Endogenous nitric oxide in present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181:852-857.
6. Kharitonov, S. A., D. H. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
7. Kharitonov, S. A., F. K. Chung, D. J. Evans, B. J. O'Connor, and P. J. Barnes. 1996. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am. J. Respir. Crit. Care Med. 153:1773-1780.
8. Alving, K., E. Weitzberg, and J. M. Lundberg. 1993. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6:1368-1370.
9. Massaro, A. F., B. Gaston, D. Kita, C. Fanta, J. S. Stamler, and J. M. Drazen. 1995. Expired nitric oxide levels during treatment of acute asthma. Am. J. Respir. Crit. Care Med. 152:800-803.
10. Asano, K., C. B. Chee, B. Gaston, C. M. Lilly, C. Gerard, J. M. Drazen, and J. S. Stamler. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 91:10089-10093.
11. Shaul, P. W., A. J. North, L. C. Wu, L. B. Wells, T. S. Brannon, K. S. Lau, T. Michel, L. R. Margraf, and R. A. Star. 1994. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J. Clin. Invest. 94:2231-2236.
12. Kobzik, L., D. S. Bredt, C. J. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler. 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9:371-377.
13. Hamid, Q., D. R. Springall, V. Riveros-Moreno, P. Chanez, P. Howarth, A. Redington, J. Bousquet, P. Godard, S. Holgate, and J. M. Polak. 1993. Induction of nitric synthase in asthma. Lancet 342:1510-1513.
14. Tracey, W. R., C. Xue, V. Klinghoffer, J. Barlow, J. S. Pollock, U. Forstermann, and R. A. Johns. 1994. Immunocytochemical detection of inducible NO synthase in human lung. Am. J. Physiol. 266:L722-L727.
15. Ward, J. K., P. J. Barnes, D. R. Springall, L. Abelli, S. Tajkarimi, M. A. Yacoub, J. M. Polak, and M. G. Belvisi. 1995. Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. Am. J. Respir. Cell Mol. Biol. 13:175-184.
16. Yates, D. H., S. A. Kharitonov, R. A. Robbins, P. S. Thomas, and P. J. Barnes. 1995. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 152:892-896.
17. Yates, D. H., S. A. Kharitonov, P. S. Thomas, and P. J. Barnes. 1996. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 154:247-250.
18. 2α, on the airway resistance of healthy and asthmatic man. Clin. Sci. Mol. Med. 48:421-130.
19. 2. Lancet 344:436-438.
20. Pasargiklian, M., S. Bianco, L. Allegra, N. E. Moavero, G. Petrigni, M. Robuschi, and A. Grugni. 1977. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34:79-91.
21. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
22. Tetsuka, T., and A. R. Morrison. 1995. Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1β. Am. J. Physiol. 269:C55-C59.
23. 2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 153:572-575.
24. Robbins, R. A., D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, I. M. Adcock, V. Riveros-Moreno, S. Moncada, J. Polak, and P.J. Barnes. 1994. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198:835-843.
25. Robbins, R. A., P. J. Barnes, D. R. Springall, J. B. Warren, O. J. Kwon, L. D. Buttery, A. J. Wilson, D. A. Geller, and J. M. Polak. 1994. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 203:209-218.
26. 2-agonists on exhaled nitric oxide in asthmatic patients. Eur. Respir. J. 10:1483-1488.
27. Sanna, A., A. Kurtansky, C. Veriter, and D. Stanescu. 1994. Bronchodilator effect of inhaled nitric oxide in healthy men. Am. J. Respir. Crit. Care Med. 150(Pt. 1):1702-1704.
28. Hogman, M., C. G. Frostell, H. Hedenstrom, and G. Hedenstierna. 1993. Inhalation of nitric oxide modulates adult human bronchial tone. Am. Rev. Respir. Dis. 148(Pt. 1):1474-1478.
29. Kuo, H. P., S. Liu, and P. J. Barnes. 1992. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Eur. J. Pharmacol. 221:385-388.
30. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 91:12168-12172.
31. Salvemini, D., K. Seibert, J. L. Masferrer, T. P. Misko, M. G. Currie, and P. Needleman. 1994. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93:1940-1947.
32. McDaniel, M. L., G. Kwon, J. R. Hill, C. A. Marshall, and J. A. Corbett. 1996. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24-32.
33. Corbett, J. A., G. Kwon, M. H. Marino, C. P. Rodi, P. M. Sullivan, J. Turk, and M. L. McDaniel. 1996. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am. J. Physiol. 270:C1581-C1587.
34. Salvemini, D., P. T. Manning, B. S. Zweifel, K. Seibert, J. Connor, M. G. Currie, P, Needleman, and J. L. Masferrer. 1995. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:301-308.